MYnd Analytics Inc. received a noncompliance notice from the Nasdaq Stock Market for failure to comply with the required minimum $2.5 million in stockholders' equity.

The company reported in its quarterly report on Form 10-Q for the period ended Dec. 31, 2017, that its stockholders' equity had fallen below the required minimum for continued listing on the exchange.

Moreover, the Mission Viejo, Calif.-based predictive analytics company also failed to meet the alternative compliance standards relating to the market value of listed securities or net income from continuing operations.

The noncompliance notice has had no immediate impact on the continued listing or trading of MYnd Analytics' common stock on the Nasdaq Capital Market.

The company has 45 calendar days, or until April 9, to submit a plan to regain compliance.

MYnd Analytics offers objective clinical decision support to mental healthcare providers for personalized treatment of behavioral disorders, including depression, anxiety and bipolar disorder.